Ramipril Patent Expiration
Ramipril is Used for reducing the risk of myocardial infarction, stroke, and death. It was first introduced by King Pharmaceuticals Llc
Ramipril Patents
Given below is the list of patents protecting Ramipril, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Altace | US7368469 | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
Aug 30, 2020
(Expired) | King Pfizer |
| Altace | US7368469 | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
Aug 30, 2020
(Expired) | King Pharms Llc |
Ramipril's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List